Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet

Kiniksa Pharmaceuticals, Ltd. (KNSA) closed the last trading session at $24.47, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $34.83 indicates a 42.3% upside potential. The mean estimate comprises six short-term price targets with a standard deviation of $3.92. While the lowest estimate of $30 indicates a 22.6% increase from the current price level, the most optimist ...